Whole Exome Sequencing of Signet Ring/Plasmacytoid Variant Bladder Cancer
Demographics (1)
- sex - Gender of participant (phv00313225.v1.p1)
Disease Events (4)
- age_onset - Disease onset age (phv00313224.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00313230.v1.p1)
- IS_TUMOR - Tumor status (phv00313229.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00313232.v1.p1)
Other (10)
- ANALYTE_TYPE - Analyte Type (phv00313228.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00313227.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00313219.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00313231.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00313226.v1.p1)
- SAMPLE_ID - Sample ID (phv00313221.v1.p1)
- SAMPLE_USE - Sample use. Seq_DNA_SNP_MAF_Sum: Samples were used to generate aggregate mutation annotation file (.maf); Seq_DNA_WholeExome: Whole exome sequencing (phv00313222.v1.p1)
- SUBJECT_ID - Subject ID (phv00313220.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00313223.v1.p1)
- SUBJECT_ID - Subject ID (phv00313218.v1.p1)